Logo image of MDM.PA

MAISONS DU MONDE SA (MDM.PA) Stock Fundamental Analysis

Europe - EPA:MDM - FR0013153541 - Common Stock

1.822 EUR
+0.08 (+4.47%)
Last: 9/18/2025, 10:27:31 AM
Fundamental Rating

2

MDM gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 53 industry peers in the Specialty Retail industry. Both the profitability and financial health of MDM have multiple concerns. MDM has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year MDM has reported negative net income.
In the past year MDM had a positive cash flow from operations.
Of the past 5 years MDM 4 years were profitable.
Each year in the past 5 years MDM had a positive operating cash flow.
MDM.PA Yearly Net Income VS EBIT VS OCF VS FCFMDM.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

1.2 Ratios

Looking at the Return On Assets, with a value of -11.35%, MDM is doing worse than 79.25% of the companies in the same industry.
MDM has a worse Return On Equity (-41.46%) than 79.25% of its industry peers.
Industry RankSector Rank
ROA -11.35%
ROE -41.46%
ROIC N/A
ROA(3y)-1.72%
ROA(5y)-0.18%
ROE(3y)-5.33%
ROE(5y)-0.77%
ROIC(3y)N/A
ROIC(5y)N/A
MDM.PA Yearly ROA, ROE, ROICMDM.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

Looking at the Gross Margin, with a value of 65.62%, MDM belongs to the top of the industry, outperforming 94.34% of the companies in the same industry.
MDM's Gross Margin has been stable in the last couple of years.
MDM does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 65.62%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.04%
GM growth 5Y-0.25%
MDM.PA Yearly Profit, Operating, Gross MarginsMDM.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

1

2. Health

2.1 Basic Checks

MDM does not have a ROIC to compare to the WACC, probably because it is not profitable.
MDM has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, MDM has less shares outstanding
MDM has a worse debt/assets ratio than last year.
MDM.PA Yearly Shares OutstandingMDM.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
MDM.PA Yearly Total Debt VS Total AssetsMDM.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

Based on the Altman-Z score of 0.65, we must say that MDM is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 0.65, MDM is not doing good in the industry: 66.04% of the companies in the same industry are doing better.
The Debt to FCF ratio of MDM is 11.56, which is on the high side as it means it would take MDM, 11.56 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 11.56, MDM perfoms like the industry average, outperforming 50.94% of the companies in the same industry.
MDM has a Debt/Equity ratio of 1.03. This is a high value indicating a heavy dependency on external financing.
MDM has a worse Debt to Equity ratio (1.03) than 67.92% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.03
Debt/FCF 11.56
Altman-Z 0.65
ROIC/WACCN/A
WACC2.99%
MDM.PA Yearly LT Debt VS Equity VS FCFMDM.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.3 Liquidity

A Current Ratio of 0.63 indicates that MDM may have some problems paying its short term obligations.
MDM's Current ratio of 0.63 is on the low side compared to the rest of the industry. MDM is outperformed by 83.02% of its industry peers.
MDM has a Quick Ratio of 0.63. This is a bad value and indicates that MDM is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.25, MDM is not doing good in the industry: 83.02% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.63
Quick Ratio 0.25
MDM.PA Yearly Current Assets VS Current LiabilitesMDM.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

1

3. Growth

3.1 Past

MDM shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -889.53%.
MDM shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -10.98%.
Measured over the past years, MDM shows a decrease in Revenue. The Revenue has been decreasing by -4.00% on average per year.
EPS 1Y (TTM)-889.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-212.55%
Revenue 1Y (TTM)-10.98%
Revenue growth 3Y-8.7%
Revenue growth 5Y-4%
Sales Q2Q%-9.7%

3.2 Future

The Earnings Per Share is expected to grow by 2.56% on average over the next years.
Based on estimates for the next years, MDM will show a decrease in Revenue. The Revenue will decrease by -0.60% on average per year.
EPS Next Y-51.8%
EPS Next 2Y9.26%
EPS Next 3Y10.23%
EPS Next 5Y2.56%
Revenue Next Year-8.39%
Revenue Next 2Y-3.28%
Revenue Next 3Y-1.61%
Revenue Next 5Y-0.6%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
MDM.PA Yearly Revenue VS EstimatesMDM.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M 1B
MDM.PA Yearly EPS VS EstimatesMDM.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 0.5 -0.5 1 1.5

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MDM. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for MDM. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MDM.PA Price Earnings VS Forward Price EarningsMDM.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

92.45% of the companies in the same industry are more expensive than MDM, based on the Enterprise Value to EBITDA ratio.
MDM's Price/Free Cash Flow ratio is rather cheap when compared to the industry. MDM is cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 1.11
EV/EBITDA 3.03
MDM.PA Per share dataMDM.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20 25

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y9.26%
EPS Next 3Y10.23%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 6.42%, MDM is a good candidate for dividend investing.
The stock price of MDM dropped by -29.68% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
MDM's Dividend Yield is rather good when compared to the industry average which is at 3.39. MDM pays more dividend than 100.00% of the companies in the same industry.
MDM's Dividend Yield is rather good when compared to the S&P500 average which is at 2.38.
Industry RankSector Rank
Dividend Yield 6.42%

5.2 History

The dividend of MDM decreases each year by -33.70%.
Dividend Growth(5Y)-33.7%
Div Incr Years0
Div Non Decr Years0
MDM.PA Yearly Dividends per shareMDM.PA Yearly Dividends per shareYearly Dividends per share 2018 2019 2021 2022 2023 2024 0.1 0.2 0.3 0.4 0.5

5.3 Sustainability

The earnings of MDM are negative and hence is the payout ratio. MDM will probably not be able to sustain this dividend level.
DP-1.39%
EPS Next 2Y9.26%
EPS Next 3Y10.23%
MDM.PA Yearly Income VS Free CF VS DividendMDM.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

MAISONS DU MONDE SA

EPA:MDM (9/18/2025, 10:27:31 AM)

1.822

+0.08 (+4.47%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)07-25 2025-07-25
Earnings (Next)10-23 2025-10-23
Inst Owners49.09%
Inst Owner ChangeN/A
Ins Owners0.15%
Ins Owner ChangeN/A
Market Cap71.40M
Analysts50
Price Target2.41 (32.27%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 6.42%
Yearly Dividend0.06
Dividend Growth(5Y)-33.7%
DP-1.39%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-4.7%
PT rev (3m)-30.39%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-62.02%
EPS NY rev (3m)-62.02%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-2.13%
Revenue NY rev (3m)-3.14%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.07
P/FCF 1.11
P/OCF 0.81
P/B 0.18
P/tB N/A
EV/EBITDA 3.03
EPS(TTM)-4.34
EYN/A
EPS(NY)-0.45
Fwd EYN/A
FCF(TTM)1.65
FCFY90.37%
OCF(TTM)2.24
OCFY123.01%
SpS25.03
BVpS10.25
TBVpS-2.29
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -11.35%
ROE -41.46%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 65.62%
FCFM 6.58%
ROA(3y)-1.72%
ROA(5y)-0.18%
ROE(3y)-5.33%
ROE(5y)-0.77%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.04%
GM growth 5Y-0.25%
F-Score5
Asset Turnover0.67
Health
Industry RankSector Rank
Debt/Equity 1.03
Debt/FCF 11.56
Debt/EBITDA 1.75
Cap/Depr 8.68%
Cap/Sales 2.38%
Interest Coverage N/A
Cash Conversion 37.09%
Profit Quality N/A
Current Ratio 0.63
Quick Ratio 0.25
Altman-Z 0.65
F-Score5
WACC2.99%
ROIC/WACCN/A
Cap/Depr(3y)24.05%
Cap/Depr(5y)25.74%
Cap/Sales(3y)3.48%
Cap/Sales(5y)3.66%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-889.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-212.55%
EPS Next Y-51.8%
EPS Next 2Y9.26%
EPS Next 3Y10.23%
EPS Next 5Y2.56%
Revenue 1Y (TTM)-10.98%
Revenue growth 3Y-8.7%
Revenue growth 5Y-4%
Sales Q2Q%-9.7%
Revenue Next Year-8.39%
Revenue Next 2Y-3.28%
Revenue Next 3Y-1.61%
Revenue Next 5Y-0.6%
EBIT growth 1Y-437.83%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year6424.15%
EBIT Next 3Y331.79%
EBIT Next 5Y189.13%
FCF growth 1Y-60.97%
FCF growth 3Y-11.59%
FCF growth 5Y-6.1%
OCF growth 1Y-59.72%
OCF growth 3Y-13.81%
OCF growth 5Y-8.3%